''Should the child be raised as male or female?'' The evaluation and management of different causes of ambiguous genital appearance in children

Abstract

Diagnosing, managing and assigning gender for different causes of ambiguous genitalia in children can be challenging. This article will discuss about the types, diagnosis and treatment of disorders of sex development including congenital adrenal hyperplasia, 46 XY mixed gonadal dysgenesis and 46XY ovotesticular disorder of sex development. This article reports about 3 cases of disorders of sex development. The first case is about a three-year-old girl who was diagnosed with congenital adrenal hyperplasia, genital examination revealed clitoromegaly and a single urogenital sinus; she was managed medically and surgically. The second case is about a one-month-old child with 46XY karyotype, genital examination revealed penoscrotal hypospadias with right palpable and left impalpable gonads. Patient underwent diagnostic laparoscopy in which both female and male internal organs were found; based on these results a diagnosis of 46XY ovotesticular disorder of sex development was made. The third case is about a 3-month-old child with 46XY karyotype, genital examination revealed hypospadias with bilateral impalpable gonads. Diagnostic laparoscopy showed a uterus with a bilateral ovary-looking gonad; histopathology of the bilateral ovary-looking gonads was consistent with testicular tissue. Based on the above, a diagnosis of 46XY mixed gonadal dysgenesis was made. Disorders of sex development are classified into three main categories based on the karyotype, XX, XY and sex chromosome other than XX and XY. Laboratory investigations, karyotype, genetic analysis, imaging, surgery and tissue biopsy, all aid in diagnosing, deciding gender identity and managing different types of disorders of sex development.

Keywords

• Ambiguous genitalia
• disorders of sex development
• ovotesticular disorder
• mixed gonadal dysgenesis

References

1. 1. Hughes IA, Nihoul-Fékété C, Thomas B, Cohen-Kettenis PT. Consequences of the ESPE/LWPES guidelines for diagnosis and treatment of disorders of sex development. Best Pract Res Clin Endocrinol Metab 2007;21:351-65.
2. 2. Blackless M, Charuvastra A, Derryck A, Fausto-Sterling A, Lauzanne K, Lee E. How sexually dimorphic are we? Review and synthesis. Am J Hum Biol 2000;12:151-66.
3. 3. Thyen U, Lanz K, Holterhus PM, Hiort O. Epidemiology and initial management of ambiguous genitalia at birth in Germany. Horm Res 2006;66:195-203.
4. 4. Forest MG. Pattern of the response of testosterone and its precursors to human chorionic gonadotropin stimulation in relation to age in infants and children. J Clin Endocrinol Metab 1979;49:132-7.
5. 5. Faisal Ahmed S, Iqbal A, Hughes IA. The testosterone: androstenedione ratio in male undermasculinization. Clin Endocrinol (Oxf) 2000;53:697-702.
6. 6. Phillip M, De Boer C, Pilpel D, Karplus M, Sofer S. Clitoral and penile sizes of full term newborns in two different ethnic groups. J Pediatr Endocrinol Metab 1996;9:175-9.
7. 7. Oberfield SE, Mondok A, Shahrivar F, Klein JF, Levine LS. Clitoral size in full-term infants. Am J Perinatol 1989;6:453-4.
8. 8. Castets S, Nguyen KA, Plaisant F, Prudon MB, Plotton I, Kassai B, et al. Reference values for the external genitalia of full-term and pre-term female neonates. Arch Dis Child Fetal Neonatal Ed 2021;106:39-44.

9. 9. González R, Ludwikowski BM. Should CAH in females be classified as DSD? Front Pediatr 2016;4:48.
10. 10. Crouch NS, Liao LM, Woodhouse CR, Conway GS, Creighton SM. Sexual function and genital sensitivity following feminizing genitoplasty for congenital adrenal hyperplasia. J Urol 2008;179:634-8.
11. 11. Lee PA, Houk CP. Review of outcome information in 46,XX patients with congenital adrenal hyperplasia assigned/reared male: what does it say about gender assignment? Int J Pediatr Endocrinol 2010; 2010:982025.
12. 12. de Jesus LE, Costa EC, Dekermacher S. Gender dysphoria and XX congenital adrenal hyperplasia: how frequent is it? Is male-sex rearing a good idea? J Pediatr Surg 2019; 54:2421-7.
13. 13. Salle JL, Lorenzo AJ, Jesus LE, Leslie B, AlSaid A, Macedo FN, et al. Surgical treatment of high urogenital sinuses using the anterior sagittal transrectal approach: a useful strategy to optimize exposure and outcomes. J Urol 2012;187:1024-31.
14. 14. Ludwikowski BM, González R. The surgical correction of urogenital sinus in patients with DSD: 15 years after description of total urogenital mobilization in children. Front Pediatr 2013;1:41.
15. 15. Merke DP, Poppas DP. Management of adolescents with congenital adrenal hyperplasia. Lancet Diabetes Endocrinol 2013;1:341-52.
16. 16. Hryhorczuk AL, Phelps AS, Yu RN, Chow JS. The radiologist's role in assessing differences of sex development. Pediatr Radiol 2022;52:752-64.
17. 17. Andrade JGR, Andrade LALA, Guerra-Junior G, Maciel-Guerra AT. 45, X/46, XY ovotesticular disorder of sex development revisited: Undifferentiated gonadal tissue may be mistaken as ovarian tissue. J Pediatr Endocrinol Metab 2017;30:899-904.
18. 18. Verkauskas G, Jaubert F, Lortat-Jacob S, Malan V, Thibaud E, Nihoul-Fékété C. The long-term followup of 33 cases of true hermaphroditism: a 40-year experience with conservative gonadal surgery. J Urol 2007;177:726-31; discussion 731.
19. 19. Sircili MH, Denes FT, Costa EM, Machado MG, Inacio M, Silva RB, et al. Long-term followup of a large cohort of patients with ovotesticular disorder of sex development. J Urol 2014;191(5 Suppl):1532-6.
20. 20. Lee PA, Nordenström A, Houk CP, Ahmed SF, Auchus R, Baratz A, et al; Global DSD Update Consortium. Global Disorders of Sex Development Update since 2006: Perceptions, Approach and Care. Horm Res Paediatr 2016;85:158-80.
21. 21. Feldman KW, Smith DW. Fetal phallic growth and penile standards for newborn male infants. J Pediatr 1975;86:395-8.
22. 22. Lee MM, Donahoe PK, Silverman BL, Hasegawa T, Hasegawa Y, Gustafson ML, et al. Measurements of serum müllerian inhibiting substance in the evaluation of children with nonpalpable gonads. N Engl J Med 1997;336:1480-6.
23. 23. Rey RA, Belville C, Nihoul-Fékété C, Michel-Calemard L, Forest MG, Lahlou N, et al. Evaluation of gonadal function in 107 intersex patients by means of serum antimüllerian hormone measurement. J Clin Endocrinol Metab 1999;84:627-31.
24. 24. Ostrer H. 46,XY disorder of Sex development and 46.XY complete gonadal dysgenesis. Seattle: GeneReviewsSeries; 1993.
25. 25. Fallat ME, Donahoe PK. Intersex genetic anomalies with malignant potential. Curr Opin Pediatr 2006;18:305-11.
26. 26. Swyer GI. Male pseudohermaphroditism: a hitherto undescribed form. Br Med J 1955;2; 709-12.
27. 27. Cools M, Drop SL, Wolffenbuttel KP. Germ cell tumors in the intersex gonad: old paths, new directions, moving frontiers. Endocr Rev 2006;27:468-84.
28. 28. Rocha VB, Guerra-Junior G, Marques-de-Faria AP. Complete gonadal dysgenesis in clinical practice: the 46,XY karyotype accounts for more than one third of cases. Fertil Steril 2011;96:1431-4.
29. 29. Pleskacova J, Hersmus R, Oosterhuis JW. Tumor risk in disorders of sex development. Sex Dev 2010;4:259-69.
30. 30. McCann-Crosby B, Mansouri R, Dietrich JE, McCullough LB, Sutton VR, Austin EG, et al. State of the art review in gonadal dysgenesis: challenges in diagnosis and management. Int J Pediatr Endocrinol 2014;2014:4.
31. 31. Timing of elective surgery on the genitalia of male children with particular reference to the risks, benefits, and psychological effects of surgery and anesthesia. American Academy of Pediatrics. Pediatrics 1996;97:590-4.